- Home
- INSP vs ARWR Comparison
INSP vs ARWR Comparison
Compare INSP & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INSP | ARWR |
|---|---|---|
| Founded | 2007 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 9.6B |
| IPO Year | 2018 | 1993 |
Fundamental Metrics
Financial Performance| Metric | INSP | ARWR |
|---|---|---|
| Price | $94.06 | $69.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 10 |
| Target Price | ★ $137.50 | $63.70 |
| AVG Volume (30 Days) | 2.4M | ★ 3.2M |
| Earning Date | 02-09-2026 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.77 | N/A |
| EPS | ★ 1.48 | N/A |
| Revenue | ★ $882,622,000.00 | $829,448,000.00 |
| Revenue This Year | $14.97 | N/A |
| Revenue Next Year | $11.81 | N/A |
| P/E Ratio | $66.34 | ★ N/A |
| Revenue Growth | 16.81 | ★ 23258.15 |
| 52 Week Low | $70.77 | $9.57 |
| 52 Week High | $216.01 | $72.36 |
Technical Indicators
Market Signals| Indicator | INSP | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 37.20 | 69.79 |
| Support Level | $89.94 | $59.51 |
| Resistance Level | $101.59 | $72.36 |
| Average True Range (ATR) | 7.89 | 3.90 |
| MACD | -6.27 | -0.47 |
| Stochastic Oscillator | 7.32 | 78.21 |
Price Performance
Historical ComparisonAbout INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.